GlassScriptPhysician profile
Maruthi Srikanth Penumetsa
NPI 1043469471
$39,651.16
in general payments reported to CMS, 2019-2025
28 companies · $562 in 2025
The $562 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,193 · 2020: $5,652 · 2021: $19K · 2022: $5,360 · 2023: $2,304 · 2024: $3,428 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,561 · Food and Beverage: $2,633 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,561.02 |
| Food and Beverage | $2,632.62 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $34,901.18 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,776.21 | 2019-2025 | Diamondback Coronary, Xience Skypoint |
| Baylis Medical Company INC | $990.56 | 2019 | |
| Medtronic, INC. | $444.07 | 2022-2025 | Ffrangio, Symplicity G3, Corevalve Evolut R |
| Abiomed | $242.16 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $182.39 | 2022-2023 | Camzyos, Eliquis |
| Angiodynamics, INC. | $132.65 | 2020-2023 | Angiovac |
| Boston Scientific Corporation | $116.97 | 2019-2023 | Watchman Access System |
| Cardiovascular Systems INC. | $113.90 | 2020-2023 | Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2023 | Brilinta |
| Janssen Pharmaceuticals, INC | $97.68 | 2019-2022 | |
| Inari Medical, INC. | $80.59 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heartflow, INC. | $79.16 | 2023 | Ffrct |
| Amgen INC. | $61.82 | 2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.45 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $49.25 | 2019-2022 | |
| Irhythm Technologies, INC. | $37.86 | 2023 | Zio Xt Patch |
| Cardinal Health 200 LLC | $24.13 | 2021 | |
| Teleflex LLC | $23.18 | 2020 | |
| Livanova USA, INC. | $16.99 | 2023 | Lifesparc |
| Regeneron Healthcare Solutions, INC. | $16.94 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.12 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $15.89 | 2020 | |
| Philips North America LLC | $15.04 | 2019 | |
| Cardiva Medical, INC. | $14.68 | 2022 | |
| Amarin Pharma, INC. | $14.61 | 2021 | |
| Pfizer INC. | $14.04 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maruthi Penumetsa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.